Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study

Clinical trial NCT03575598 · COMPLETED

Trial details

NCT number: NCT03575598
Sponsor: University Health Network, Toronto
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Squamous Cell Carcinoma, Head And Neck Squamous Cell Carcinoma Mouth Squamous Cell Carcinoma of the Oral Cavity

Start date: 2018-08-30
Primary completion: 2020-02-18
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.